Quantitative assessment of macrophage functions in repair and fibrosis

Current Protocols in Immunology

Volumn , Issue SUPPL.93, 2011, Pages

  Wynn, Thomas A ^a   Barron, Luke ^a   Thompson, Robert W ^a   Madala, Satish K ^a   Wilson, Mark S ^a   Cheever, Allen W ^a   Ramalingam, Thirumalai ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Collagen; Fibrosis; Hydroxyproline; Immunosuppression; Remodeling; Urea

Indexed keywords

ARGINASE 1; ARGININE; COLLAGEN; HYDROXYPROLINE; UREA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; COLLAGEN SYNTHESIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROSIS; LUNG LAVAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SUPPRESSOR CELL; T LYMPHOCYTE; UREA CYCLE; WOUND HEALING;

EID: 82355181246     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bronte, V. and Zanovello, P. 2005. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5:641-654.
2. Chiaramonte, M.G., Donaldson, D.D., Cheever, A.W., and Wynn, T.A. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104:777-785.
3. El Kasmi, K.C., Qualls, J.E., Pesce, J.T., Smith, A.M., Thompson, R.W., Henao-Tamayo, M., Basaraba, R.J., König, T., Schleicher, U., Koo, M.S., Kaplan, G., Fitzgerald, K.A., Tuomanen, E.I., Orme, I.M., Kanneganti, T.D., Bogdan, C., Wynn, T.A., and Murray, P.J. 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9:1399-1406.
4. Gordon, M.K. and Hahn, R.A. 2010. Collagens. Cell Tissue Res. 339:247-257.
5. Gordon, S. 1999. Macrophages and the immune response. In Fundamental Immunology (W.E. Paul, ed.) pp. 533-544. Lippincott-Raven Publishers, Philadelphia.
6. Gordon, S. 2003. Alternative activation of macrophages. Nat. Rev. Immunol. 3:23-35.
7. Hesse,M., Modolell, M., La Flamme, A.C., Schito, M., Fuentes, J.M., Cheever, A.W., Pearce, E.J., and Wynn, T.A. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: Granulomatous pathology is shaped by the pattern of Larginine metabolism. J. Immunol. 167:6533-6544.
8. Modolell, M., Corraliza, I.M., Link, F., Soler, G., and Eichmann, K. 1995. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 25:1101-1104.
9. Mosser, D.M. and Edwards, J.P. 2008. Exploring the full spectrum ofmacrophage activation. Nat. Rev. Immunol. 8:958-969.
10. Pesce, J., Kaviratne, M., Ramalingam, T.R., Thompson, R.W., Urban, J.F. Jr., Cheever, A.W., Young, D.A., Collins, M., Grusby, M.J., and Wynn, T.A. 2006. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest. 116:2044-2055.
11. Pesce, J.T., Ramalingam, T.R., Mentink-Kane, M.M., Wilson, M.S., El Kasmi, K.C., Smith, A.M., Thompson, R.W., Cheever, A.W., Murray, P.J., andWynn, T.A. 2009. Arginase-1-expressing macrophages suppress Th2 cytokinedriven inflammation and fibrosis. PLoS Pathog. 5:e1000371.
12. Rutschman, R., Lang, R., Hesse, M., Ihle, J.N., Wynn, T.A., and Murray, P.J. 2001. Cutting edge: Stat6-Dependent substrate depletion regulates nitric oxide production. J. Immunol. 166:2173-2177.
13. Thompson, R.W., Pesce, J.T., Ramalingam, T., Wilson, M.S., White, S., Cheever, A.W., Ricklefs, S.M., Porcella, S.F., Li, L., Ellies, L.G., andWynn, T.A. 2008. Cationic amino acid transporter-2 regulates immunity by modulating arginase activity. PLoS Pathog. 4:e1000023.
14. Wilson, M.S. and Wynn, T.A. 2009. Pulmonary fibrosis: Pathogenesis, etiology and regulation. Mucosal. Immunol. 2:103-121.
15. Wynn, T.A. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4:583-594.
16. Wynn, T.A. 2008. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214:199-210.